Moreover, as demonstrated in this study, the activation of Wnt4 signaling is required by low level of DIM in promoting gastric cancer progression, probably simultaneous targeting Wnt4 may help improve therapeutic efficacy. This evidence concerns the gene WNT4 and gastric cancer.